Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Disease; Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06560151
What this trial is testing

Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59

Who this might be right for
Influenza
Biomedical Advanced Research and Development Authority 1,380
Testing effectiveness (Phase 2)Study completedNCT01896154
What this trial is testing

Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity

Who this might be right for
Immunosenescence
Clinical Research Center Kiel GmbH 239
Early research (Phase 1)Study completedNCT00489931
What this trial is testing

Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 44
Not applicableStudy completedNCT00570037
What this trial is testing

Feasibility of Cocooning Immunization Strategy With Influenza Vaccine

Who this might be right for
Influenza
Duke University 544
Post-approval studies (Phase 4)Study completedNCT00743275
What this trial is testing

Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 120
Large-scale testing (Phase 3)Study completedNCT03390166
What this trial is testing

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Who this might be right for
Influenza
Mahidol University 945
Testing effectiveness (Phase 2)Study completedNCT03682120
What this trial is testing

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 372
Testing effectiveness (Phase 2)Study completedNCT00742885
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Who this might be right for
Influenza
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Study completedNCT00980850
What this trial is testing

Swine Flu (Novel Influenza A H1N1) Vaccine Study

Who this might be right for
Influenza
University of Oxford 1,000
Early research (Phase 1)Study completedNCT05755620
What this trial is testing

Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT03698279
What this trial is testing

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 665
Post-approval studies (Phase 4)Study completedNCT00556062
What this trial is testing

Phase IV Clinical Trial of an Influenza Split Vaccine Anflu

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 566
Post-approval studies (Phase 4)Study completedNCT00192140
What this trial is testing

Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

Who this might be right for
Influenza
MedImmune LLC 345
Not applicableUnknownNCT04110990
What this trial is testing

Retrospective Observational Study on the Epidemiological Characteristics of Influenza Patients

Who this might be right for
Influenza
University Hospital, Strasbourg, France 384
Early research (Phase 1)Study completedNCT02877160
What this trial is testing

Assess the PK of AL-794 Formulations in Healthy Subjects

Who this might be right for
Influenza
Alios Biopharma Inc. 31
Not applicableStudy completedNCT01408290
What this trial is testing

Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 256
Large-scale testing (Phase 3)Study completedNCT05269290
What this trial is testing

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold
Valenta Pharm JSC 240
Large-scale testing (Phase 3)UnknownNCT03900988
What this trial is testing

Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia

Who this might be right for
Influenza
Chinese University of Hong Kong 160
Post-approval studies (Phase 4)Study completedNCT01404182
What this trial is testing

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 121
Not applicableStudy completedNCT01979588
What this trial is testing

How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice

Who this might be right for
Influenza Like IllnessAsthmaGroup A Streptococcal Infection+1 more
Endeavor Health 206,703
Next Page